MetLife Continues To Languish In An Out-Of-Favor Sector

Maybe the nicest thing I can say about MetLife (MET) is that it has suffered no worse than its sector, with the shares down 4% over the past year and more or less in line with Lincoln (LNC) and Prudential (PRU), while Unum (UNM) has fallen more than 20%. The issues for investors remain more or less the same – worries about spread pressure, worries about credit quality risk in fixed income, worries about the growth potential of mature markets, and probably most importantly, worries about the status of reserves in long-term care insurance books.

I continue to believe MetLife is undervalued, but it’s hard to identify a catalyst for a turnaround in sentiment. A successful/benign completion of its actuarial review of its LTC business would certainly help, but I think investors are firmly in the “we’ll believe it when we see it” camp when it comes to the potential of the LTC business, as well as the company’s cost-cutting targets and growth initiatives. I continue to see fair value in the low-to-mid $50s, which when combined with the dividend, suggests a pretty good return for this unpopular name.

Read the full article here:
MetLife Continues To Languish In An Out-Of-Favor Sector

MetLife Moving Past Some Self-Inflicted Challenges And Toward Unlocking Value

MetLife's (MET) performance over the past year hasn't been all that good, but it has at least been better than that of many of its peers. Although MetLife has done a lot to clean up and improve its business, the company still has a track record of inconsistent results (often punctuated by large charges) and headwinds like lower returns on equity from its run-off business and spread compression in its U.S. retirement business.

I think expectations for MetLife are low and that the shares could be positioned to outperform as a result. The company's earnings growth outlook is rather modest, and that is a concern, but I do believe book value growth should improve from here and exceed core earnings growth. If and as that happens, the multiple should expand and MetLife should get more of its due, but investors should appreciate that this name is highly likely to be more tortoise than hare.

Read more here:
MetLife Moving Past Some Self-Inflicted Challenges And Toward Unlocking Value

Investopedia: When Will Genworth's Turnaround Come?

There's still ample economic wreckage from the housing bubble and crash, but many participants have clawed their way back and are starting to see signs of normalization. Major mortgage issuers like Wells Fargo (NYSE:WFC) are back to paying dividends and thinking about long-term growth strategies, while insurance companies like MetLife (NYSE:MET) are largely secure from a capital standpoint (even if U.S. regulators don't completely agree).
Genworth (NYSE:GNW) is a different case. While the stock and company are clearly back from the brink of complete ruin (the stock traded for less than 90 cents just over three years ago), the company is not exactly strong or thriving again. The resignation of the company's CEO may facilitate a better turnaround strategy, but investors considering these shares are going to have to have patience to see the investment work out.

Please read more here:
http://stocks.investopedia.com/stock-analysis/2012/When-Will-Genworths-Turnaround-Come-GNW-MET-UNM-PRU0615.aspx